{"id":"W2562790498","doi":"10.1093/annonc/mdw607","title":"Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Cancer Research UK","keywords":"Dasatinib; Gemcitabine; Medicine; Internal medicine; Placebo; Oncology; Clinical endpoint; Pancreatic cancer; Phases of clinical research; Clinical trial; Cancer; Pathology; Tyrosine kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001593187,0.002661823,0.005252064,0.0005492129,0.0005777403,0.001559436,0.001321642,0.002378691,0.009845332],"category_scores_gemma":[0.002045058,0.00127631,0.002051575,0.0005156511,0.001776067,0.002107382,0.0005326401,0.00521531,0.00196534],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00097322,"about_ca_system_score_gemma":0.001512712,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007503329,"about_ca_topic_score_gemma":0.002117578,"domain_scores_codex":[0.9993547,0.000284761,0.00004184859,0.0001640546,0.00004181209,0.0001129315],"domain_scores_gemma":[0.9992266,0.0001959355,0.0001411004,0.00008980888,0.00005387544,0.0002926701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9801729,0.005815678,0.0002041243,0.0006360672,0.0006034118,0.00003258307,0.00005308032,0.0003160939,0.002501042,0.00009866185,0.0008790251,0.008687304],"study_design_scores_gemma":[0.9740635,0.02446696,0.0004185862,0.00001250767,0.0001157214,0.00002127636,0.00001450137,0.0001785135,0.00022246,0.00008404032,0.0003912991,0.0000105396],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763404,0.007146533,0.001279372,0.001626464,0.001788836,0.005734005,0.002109877,0.0003935026,0.003581148],"genre_scores_gemma":[0.9792725,0.00341019,0.0019736,0.001546709,0.0005628566,0.005471872,0.001803847,0.00006517689,0.005893185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009845332,"threshold_uncertainty_score":0.03293598,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1136095383442242,"score_gpt":0.4626879517170715,"score_spread":0.3490784133728473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}